Call to Action for Dengue Vaccine Failure

Call to Action for Dengue Vaccine Failure

Bibliographic Details
Main Authors:	Suresh Mahalingam, Belinda L. Herring, Scott B. Halstead
Format:	Article
Language:	English
Published:	Centers for Disease Control and Prevention 2013-08-01
Series:	Emerging Infectious Diseases
Subjects:	dengue virus dengue viruses vaccine vaccine failure antibody-dependent enhancement of infection
Online Access:	https://wwwnc.cdc.gov/eid/article/19/8/12-1864_article

Similar Items

Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine
by: Rahul Shukla, et al.
Published: (2020-10-01)

Japanese Encephalitis DNA Vaccines with Epitope Modification Reduce the Induction of Cross-Reactive Antibodies against Dengue Virus and Antibody-Dependent Enhancement of Dengue Virus Infection
by: Tomohiro Kotaki, et al.
Published: (2022-08-01)

Safety issues from a Phase 3 clinical trial of a live-attenuated chimeric yellow fever tetravalent dengue vaccine
by: Scott B. Halstead
Published: (2018-09-01)

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
by: Jisang Park, et al.
Published: (2020-02-01)

Safety and immunogenicity of a single dose, live-attenuated ‘tetravalent dengue vaccine’ in healthy Indian adults; a randomized, double-blind, placebo controlled phase I/II trial
by: Lalitendu Mohanty, et al.
Published: (2022-04-01)

A Model of Vaccination for Dengue in the Philippines 2016–2018
by: Pierre Magal, et al.
Published: (2021-10-01)

Biological view of vaccination described by mathematical modellings: from rubella to dengue vaccines
by: Hyun Mo Yang, et al.
Published: (2019-04-01)

Sculpting humoral immunity through dengue vaccination to enhance protective immunity
by: Wayne eCrill, et al.
Published: (2012-11-01)

Wanted Dead or Alive: A Correlate of Protection Against Dengue Virus
by: Lázaro Gil, et al.
Published: (2019-12-01)

The dengue vaccine challenges
by: Radka KOMITOV, et al.
Published: (2022-03-01)

Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement
by: Hughes Holly R, et al.
Published: (2012-06-01)

Molecular identification of dengue virus binding protein on filopodia of vero cells
by: Aliyu, Isah Abubakar
Published: (2017)

The Human Antibody Response to Dengue Virus Infection
by: Aravinda M. de Silva, et al.
Published: (2011-11-01)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
by: Maia A Rabaa, et al.
Published: (2017-09-01)

Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora’s box?
by: Shannon A. Gunawardana, et al.
Published: (2018-12-01)

Pichia pastoris-expressed Dengue 3 Envelope-based Virus-like Particles Elicit Predominantly Domain III-Focused High Titer Neutralizing Antibodies
by: Lav eTripathi, et al.
Published: (2015-09-01)

Vaccination with dengue virus-like particles induces humoral and cellular immune responses in mice
by: Zhang Quanfu, et al.
Published: (2011-06-01)

Dengue vaccine acceptance and willingness to pay
by: Harapan Harapan, et al.
Published: (2017-04-01)

Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement
by: Animesh Sarker, et al.
Published: (2023-06-01)

A Review on Dengue Vaccine Development
by: Sheng-Qun Deng, et al.
Published: (2020-02-01)

Antibody-Dependent Enhancement and Zika: Real Threat or Phantom Menace?
by: Miguel A. Martín-Acebes, et al.
Published: (2018-02-01)

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
by: Vincent Dussupt, et al.
Published: (2021-02-01)

Effective Protection Induced by a Monovalent DNA Vaccine against Dengue Virus (DV) Serotype 1 and a Bivalent DNA Vaccine against DV1 and DV2 in Mice
by: Xiaoyan Zheng, et al.
Published: (2017-05-01)

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models
by: Rahul Shukla, et al.
Published: (2020-10-01)

Frontiers in dengue virus research /
by: Hanley, Kathryn A., editor, et al.
Published: (c201)

Vaccines licensed and in clinical trials for the prevention of dengue
by: J. Torresi, et al.
Published: (2017-05-01)

Exploring dengue genome to design effective multi epitope-based peptide vaccine by immunoinformatics approach against all serotypes of dengue virus
by: Md. Sadman Sakib, et al.
Published: (2024-01-01)

Recombinant Modified Vaccinia Virus Ankara Expressing a Glycosylation Mutant of Dengue Virus NS1 Induces Specific Antibody and T-Cell Responses in Mice
by: Lucas Wilken, et al.
Published: (2023-03-01)

Anti-dengue viral activity of Carica Papaya leaves extract /
by: Siti Latifah Abd. Kadir, author 1987- 527092, et al.
Published: (2021)

Anti-dengue viral activity of Carica Papaya leaves extract /
by: Siti Latifah Abd. Kadir, author 1987- 527092
Published: (2021)

Problematic questions in the development of specific prevention of dengue fever
by: E. I. Kazachinskaia, et al.
Published: (2022-03-01)

Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
by: Lucas Wilken, et al.
Published: (2020-06-01)

Host immunity and vaccine development against Dengue virus
by: Enhao Ma, et al.
Published: (2022-03-01)

Mouse models to study dengue virus immunology and pathogenesis
by: Raphaël M. Zellweger, et al.
Published: (2014-04-01)

Development of Zika Virus Vaccines
by: Huda Makhluf, et al.
Published: (2018-01-01)

Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 studyResearch in context
by: Alix Miauton, et al.
Published: (2024-01-01)

Race against dengue
by: Swee Sen Kwek, et al.
Published: (2024-02-01)

T-cell Responses in Individuals Infected with Zika Virus and in Those Vaccinated Against Dengue Virus
by: Dominic Paquin-Proulx, et al.
Published: (2017-06-01)

Recent Developments in Recombinant Protein–Based Dengue Vaccines
by: Nagesh K. Tripathi, et al.
Published: (2018-08-01)

Understanding dengue pathogenesis: implications for vaccine design
by: Stephenson John R.
Published: (2005-01-01)